QINECSA SOLUTIONS

Live / Applied — Third extension granted (statement of use) (as of 28 Oct 2025)

What this means for you

Not registered yet, but its 13 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97753516
Mark type
Stylized text
Filed
13 Jan 2023
Published for opposition
12 Mar 2024
Attorney of record
Zachary A. Aria

Goods and services

  • Class 009 — Scientific and electric apparatus: Downloadable computer software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said reactions and events and producing reports regarding such reactions and events; downloadable computer programs for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; downloadable computer software applications for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; Downloadable computer software and downloadable computer software applications for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs
  • Class 035 — Advertising and business services: Outsourcing services, namely, arranging of service contracts and procurement of goods or services for others; business consultancy; business consulting, business assistance, and business management in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; database management in the field of drug and pharmaceutical safety testing, pharmacovigilance clinical trials, and capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; information, advisory and consultancy services relating to all the aforesaid
  • Class 041 — Education and entertainment services: Educational services, namely, classes, seminars and training in the fields of drug and pharmaceutical safety testing, pharmacovigilance clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; conducting seminars and workshops in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; publication of books; publication of electronic books and journals on-line; providing on-line non-downloadable electronic publications, namely, books, magazines, journals, texts and documents in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; information, advisory and consultancy services relating to all the aforesaid
  • Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; providing temporary use of on-line non-downloadable software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, as well as enabling follow-up questions and answers regarding said quality, reactions and events and enables the production of reports regarding said reactions and events; maintenance of computer software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals and enables follow-up questions and answers regarding said reactions and events; Scientific and technological services, namely, scientific research and design in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance; providing medical research information; medical research and product development; design and development of computer software; pharmacovigilance services for others, namely, scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; Medical and scientific research, namely, conducting clinical trials; Medical and scientific research, namely, conducting clinical trials for pharmaceutical and biotechnology products; providing medical and scientific research information in the field of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance; inspection of medicines; drug safety, namely, product quality testing and evaluation; Pharmaceutical drug development services; testing of medicines and vaccines; inspection of medicines and vaccines; information technology consulting services relating to installation, maintenance and repair of computer software for the pharmaceutical, biotechnology and healthcare industries; providing scientific information about the results of clinical trials; consultancy services in the fields of drug and pharmaceutical safety testing, medical and scientific research for clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance and pharmacovigilance, namely scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; Software as a service (SaaS) featuring software for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs; Providing on-line non-downloadable software using artificial intelligence for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs; information, advisory and consultancy services relating to all the aforesaid
  • Class 045 — Legal and security services: Consultancy services in the field of regulatory compliance and regulatory compliance auditing in the pharmaceutical field

Owner

Prosecution history

  • 28 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 28 Oct 2025 — SOU EXTENSION 3 GRANTED
  • 28 Oct 2025 — SOU EXTENSION 3 FILED
  • 28 Oct 2025 — SOU TEAS EXTENSION RECEIVED
  • 27 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 27 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 27 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 27 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 27 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 07 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 07 May 2025 — SOU EXTENSION 2 GRANTED
  • 07 May 2025 — SOU EXTENSION 2 FILED
  • 06 May 2025 — SOU TEAS EXTENSION RECEIVED
  • 31 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 31 Oct 2024 — SOU EXTENSION 1 GRANTED

View this trademark record on Marksy